Publications by authors named "P Domingo"

Claim this Profile
I
Immune reconstitution in very advanced HIV patients treated with dolutegravir vs. darunavir-based triple antiretroviral therapy: the Advanz-4 randomized clinical trial.
Jose M Miro, Ferran Torres, Christian Manzardo, Eva Bonfill, Adrià Curran, Pere Domingo

Clin Microbiol Infect· January 2026

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Integrase versus protease inhibitor therapy in advanced HIV disease (LAPTOP): a multicountry, randomised, open-label, non-inferiority trial.
Georg M N Behrens, Lambert Assoumou, Geoffroy Liegeon, Andrea Antinori, Rafael Micán, Pere Domingo

Lancet Infect Dis· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mortality and Non-Fatal Clinical Outcomes After the Most Common Cancers in People with HIV: A Multicohort Collaboration.
Alisa Timiryasova, Lauren Greenberg, Pere Domingo, Philip E Tarr, Alexander Egle

Cancers (Basel)· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Age-standardized comparison of coronary artery disease, stroke incidence, and all-cause mortality between people living with HIV and the general population in Spain.
Anna Camps-Vilaró, Ramon Teira, Isaac Subirana, Irene R Dégano, Pere Domingo

Int J Infect Dis· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Is less truly more? - reassessing antiretroviral efficacy - a safety analysis for HIV patients switching from triple to double regimens with integrase inhibitors: A systematic review and meta-analysis.
Francisco Jover, Javier Martínez-Sanz, Antonio Antela, María López-Cavanillas, Minerva Viguera-Moreno, Pere Domingo

Medicine (Baltimore)· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis